H

Helixmith Co Ltd
KOSDAQ:084990

Watchlist Manager
Helixmith Co Ltd
KOSDAQ:084990
Watchlist
Price: 6 600 KRW -2.22% Market Closed
Market Cap: 304.2B KRW

Operating Margin
Helixmith Co Ltd

-227.6%
Current
-1 011%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-227.6%
=
Operating Profit
-11.3B
/
Revenue
5B

Operating Margin Across Competitors

No Stocks Found

Helixmith Co Ltd
Glance View

Market Cap
303.9B KRW
Industry
Biotechnology

Helixmith Co., Ltd. engages in the development and sale of bio and natural substances. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-29. The firm operates its business through two segments. The Natural Products Business segment develops and sells raw materials for functional materials and health functional foods such as Alex, Murphine, and Nimosin. The New Biopharmaceutical Business segment develops diabetic neuropathy treatment, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis treatment, ischemic heart disease, and anticancer treatment.

Intrinsic Value
990.55 KRW
Overvaluation 85%
Intrinsic Value
Price
H
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-227.6%
=
Operating Profit
-11.3B
/
Revenue
5B
What is the Operating Margin of Helixmith Co Ltd?

Based on Helixmith Co Ltd's most recent financial statements, the company has Operating Margin of -227.6%.

Back to Top